Latest Breaking News On - Models of cancer therapies group - Page 1 : comparemela.com

First MYC inhibitor to demonstrate safety and anti-tumor activity in a phase I first-in-human clinical trial

First MYC inhibitor to demonstrate safety and anti-tumor activity in a phase I first-in-human clinical trial
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Laura soucekElena garraldaRaquel perez lopezEmiliano calvoRadiomics groupEarly clinical drug development groupExperimental therapeutics programModels of cancer therapies groupCatalan institute of researchUniversity hospitalsResearch unit for molecular therapy of cancerResearch professorTherapeutics programCancer therapies groupCatalan instituteAdvanced studie

Promising Preclinical Results for MYC Inhibition in Melanoma

Promising Preclinical Results for MYC Inhibition in Melanoma
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Israel generalMarianof zacarLaura soucekModels of cancer therapies groupGenes developmentSpanish ministry of economyTranslational research programHebron institute of oncologyEuropean research councilSpanish ministry of scienceCatalan institute of researchResearch professorHebron institutePrincipal investigatorCancer therapiesCatalan institute

Omomyc Mini-Protein Maintains Integrity in Tumor for 72 Hours

Omomyc Mini-Protein Maintains Integrity in Tumor for 72 Hours
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Israel generalComunidad autonoma de catalunaLaura soucekEuropean union horizonCatalan institute of researchResearch professorHebron institute of oncologySpanish ministry of scienceModels of cancer therapies groupTranslational researchCancer therapies groupHebron instituteCatalan instituteAdvanced studiesChief executive officerMarie eve beaulieu

Omomyc as the first MYC-targeted therapy to successfully complete a phase I clinical trial

Omomyc as the first MYC-targeted therapy to successfully complete a phase I clinical trial
sciencex.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencex.com Daily Mail and Mail on Sunday newspapers.

Newcastle upon tyneUnited kingdomIsrael generalLaura soucekElena garraldaRuth plummerResearch professorTranslational research programCatalan institute of researchResearch unit for molecular therapy of cancerHebron institute of oncologyNorthern centre for cancer careScientific committeeModels of cancer therapies groupEarly clinical drug development groupHebron institute